Accelerate Diagnostics Announces 510 Submission of the Accelerate Arc™ System to the FDA Apr 09, 2024 Enabling rapid, automated microbial identification.
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
TUCSON, Ariz., Jan. 7, 2024 /PRNewswire/ Accelerate Diagnostics, Inc. , an in vitro diagnostics company dedicated to providing services that improve patient outcomes and lower healthcare costs.
/PRNewswire/ Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2023. "Our.
TUCSON, Ariz., May 11, 2023 /PRNewswire/ Accelerate Diagnostics, Inc. today announced financial results for the first quarter for the period ended March 31, 2023. . | June 15, 2023